AFINITOR

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: ff956b5bd162ee36
Drug Approval Canada Name: AFINITOR
Product Name: AFINITOR
Status: Cancelled Post Market
Status Date: 2018-07-09
Original Market Date: 2016-04-05
Din: 02450267
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AH02 EVEROLIMUS
Atc Name: l 04 ah 02
Aig Number: 0152682009
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

EVEROLIMUS

7.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

ff956b5bd162ee36

Type

Standard